Nephros Inc (NEPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -306 | -7,106 | -6,258 | -3,104 | -1,967 |
| Depreciation Amortization | 54 | 351 | 296 | 196 | 92 |
| Accounts receivable | -677 | 357 | 269 | -487 | 348 |
| Other Working Capital | 31 | 432 | -249 | -732 | -329 |
| Other Operating Activity | 1,174 | 2,732 | 2,903 | 1,258 | 59 |
| Operating Cash Flow | $276 | $-3,234 | $-3,039 | $-2,869 | $-1,797 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -137 | -137 | -137 | -34 |
| Investing Cash Flow | $N/A | $-137 | $-137 | $-137 | $-34 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -74 | -286 | -206 | -137 | -70 |
| Common Stock Issued | N/A | 163 | 163 | 163 | 163 |
| Other Financing Activity | 0 | 157 | 188 | 188 | 188 |
| Financing Cash Flow | $-74 | $34 | $145 | $214 | $281 |
| Exchange Rate Effect | N/A | -2 | -2 | -2 | -2 |
| Beginning Cash Position | 3,634 | 6,973 | 6,973 | 6,973 | 6,973 |
| End Cash Position | 3,836 | 3,634 | 3,940 | 4,179 | 5,421 |
| Net Cash Flow | $202 | $-3,339 | $-3,033 | $-2,794 | $-1,552 |
| Free Cash Flow | |||||
| Operating Cash Flow | 276 | -3,234 | -3,039 | -2,869 | -1,797 |
| Capital Expenditure | N/A | -137 | -137 | -137 | -34 |
| Free Cash Flow | 276 | -3,371 | -3,176 | -3,006 | -1,831 |